NCT04342065View on ClinicalTrials.gov

Pregabalin Versus Celecoxib on Sevoflurane and Analgesic Consumption in Spine Fixation Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 30, 2020

Study Completion Date

February 1, 2020

Conditions
Post-Operative Pain
Interventions
DRUG

Celecoxib capsules

received celecoxib 200 mg 2 hours preoperative and the same dose 6 hours postoperative.

DRUG

Pregabalin 150mg

received Pregabalin 150mg 2 hours preoperative and the same dose 6 hours postoperative.

Trial Locations (1)

0020

South Egypt Cancer Institute, Assiut University, Arab Republic of Egypt, Asyut

All Listed Sponsors
lead

South Egypt Cancer Institute

OTHER

NCT04342065 - Pregabalin Versus Celecoxib on Sevoflurane and Analgesic Consumption in Spine Fixation Surgery | Biotech Hunter | Biotech Hunter